The CRISPR/Cas9 gene-editing technique has shown promise in fighting advanced colorectal cancer, according to results of the ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

In the study, researchers used CRISPR/Cas9 gene-editing to modify a type of immune cell called tumour-infiltrating ...

An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growing—but there are ...

Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

Explore gene therapy advancements with Chromatin Bioscience's innovative chromatinLENS platform for safer, more effective treatments.

Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...